Literature DB >> 15546106

Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?

P G Ambrose, D Bast, G V Doern, P B Iannini, R N Jones, K P Klugman, D E Low.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15546106     DOI： 10.1086/425508

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  Daniel E Rozen; Lesley McGee; Bruce R Levin; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.

Authors:  Arnab Majhi; Rana Adhikary; Aritra Bhattacharyya; Sayantika Mahanti; Biswadev Bishayi
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

Review 3.  Optimal pharmacological therapy for community-acquired pneumonia: the role of dual antibacterial therapy.

Authors:  Benjamin J Epstein; John G Gums
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Preferential Use of Nitrofurantoin Over Fluoroquinolones for Acute Uncomplicated Cystitis and Outpatient Escherichia coli Resistance in an Integrated Healthcare System.

Authors:  Rebecca L Pedela; Katherine C Shihadeh; Bryan C Knepper; Michelle K Haas; William J Burman; Timothy C Jenkins
Journal:  Infect Control Hosp Epidemiol       Date:  2017-01-05       Impact factor: 3.254

5.  Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis.

Authors:  Steven J Lichtenstein; David B Granet
Journal:  Clin Ophthalmol       Date:  2008-03

6.  Clinical development of 1% azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy.

Authors:  Mitchell H Friedlaender; Eugene Protzko
Journal:  Clin Ophthalmol       Date:  2007-03

7.  Effects of a Syndrome-Specific Antibiotic Stewardship Intervention for Inpatient Community-Acquired Pneumonia.

Authors:  Michelle K Haas; Kristen Dalton; Bryan C Knepper; Sarah A Stella; Lilia Cervantes; Connie S Price; William J Burman; Philip S Mehler; Timothy C Jenkins
Journal:  Open Forum Infect Dis       Date:  2016-09-01       Impact factor: 3.835
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.